CSBR:NASDAQ
Champions Oncology Inc
$4.70
0.00%
(0.00) 1D
Nov 13, 3:57:39 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65.49M
Avg. vol.
8.15K
Volume
203.00
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Mkt. cap
65.49M
Avg. vol.
8.15K
Volume
203.00
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
Benzinga
·
46 minutes ago
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
MarketWatch
·
59 minutes ago
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
BigGo Finance
·
2 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
1 hour ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com